NCT05477277View on ClinicalTrials.gov

Adverse Outcomes and Mortality in Liver Transplant

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

November 2, 2022

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2027

Conditions

End Stage Liver DIseaseSarcopeniaSarcopenic ObesityCirrhosis

Interventions

DIAGNOSTIC_TEST

MAsS

Add MAsS to standard of care MRI scan

Trial Locations (1)

85259

RECRUITING

Mayo Clinic Arizona, Phoenix

Sponsors

Lead Sponsor

Collaborators (1)

Amra Medical AB

All Listed Sponsors

collaborator

Amra Medical AB

INDUSTRY

lead

Mayo Clinic

OTHER

NCT05477277 - Adverse Outcomes and Mortality in Liver Transplant | Biotech Hunter | Biotech Hunter